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Abstract
A middle aged primigravida was managed at the University of Nigeria Teaching Hospital, Enugu,
Nigeria for a pituitary macroadenoma. She was admitted at 33 weeks gestational age following a
history of blurred vision and generalized headache, worse on bending down. After neurological
consultation and investigations, a diagnosis of pituitary macroadenoma with mass effect was
entertained. A plan for neurosurgery after delivery was made and the patient put on bromocriptine
to reduce tumour size. Premature labour at 35 weeks resulted in caesarean delivery of a live baby.
She was managed in the intensive care unit for three days where oral bromocriptine was resumed
before she was transfered to the postnatal ward. Within ten hours of the transfer, she developed
accelerated hypertension with encephalopathy and had a cardiac arrest shortly afterwards. This rare
case highlights both the possible role of bromocriptine as a cause of postpartum hypertension and the
possible development of a sudden catastrophic intramoural infarction or hemorrhage (pituitary
apoplexy) in a patient with a macroadenoma.
Introduction
The preoperative management of patients with pituitary
tumors presenting for surgery requires careful preoperative
assessmentand meticulous pre and postoperative manage-
ment especially so in the pregnant patient. Particular
problems in these parturient have to do with the primary
hormonal hyper secretion and its complications, and to
the mass effect of the tumours [1].
Knowledge of the normal physiology and anatomy of the
pituitary gland is important to allow an understanding of
path physiological effects relevant to anesthesia and of
the potential complications that might arise periopera-
tively [1].
Anaesthesia for pituitary disease is a highly specialized
area and because the reported cases are few [2], especially
during pregnancy, extensive experience in this area is often
lacking. Prolactinomas are the commonest pituitary
tumors complicating pregnancy. Based on their size
prolactinomas are classified into macroadenoma
(>1 cm) or micro adenoma (<1 cm). In this case, we
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macroadenoma presenting for caesarean delivery at the
gestational age of 34 weeks and five days.
Case presentation
A 30 year old nulliparous Nigerian woman of the
Igbo tribe presented for antenatal care at 24 weeks
gestational age. She had two visits to the hospital before
she presented to the hospital as an emergency. After a
review by the obstetrician, she was admitted to the
antenatal ward and a consult sent to the neurologist for
ar e v i e w .
The patient gave a two year history of blurring of vision,
followed a month later by generalized headache that was
worse on bending. The headache had intensified since
becoming pregnant. Of recent there had been associated
vomiting. There was also a history of menstrual irregula-
rities, urinary frequency and protrusion of the right eye.
She did not report any weakness in the limbs or trauma to
the head or eye. She had visited an ophthalmologist where
she was treated on outpatient basis.
Physical examination revealed a young woman in painful
distress, conscious and well oriented. She was not pale,
icteric or febrile to touch. Blood pressure on admission
was120/80mmHgandpulseratewas76beatsperminute,
regular and of good volume.
Examination of the central nervous system revealed
proptosis of the left eye and a blind right eye. There was
temporal visual loss with reduced acuity in the left eye.
Fundoscopy showed established optic atrophy in the right
eye with early optic atrophy changes in the left eye. Other
cranial nerves were intact with no sign of meningeal
irritation. There were no asymmetries in the limbs. The
possibility of an intracranial space occupying lesion was
entertained.
Relevant investigations were ordered. A computerized
tomography (CT) scan of the brain showed a large
pituitary tumour (>10 mm) with pressure effects, occlud-
ing the anterior horn of the left lateral ventricle. The other
ventricles were dilated.
The results of other investigations were as follows – serum
prolactin 250 ng/ml (6.0-24), serum T3 2.4 ng/ml
(0.6-1.6), serum cortisol 310 ng/ml (50-230) and fasting
blood sugar 69 mg/dl (65-110). Abdominopelivic ultra-
sound scan revealed a live singleton fetus at 33 weeks
with cephalic presentation and anterior placenta. The
fetal heart rate was 130/minute.
A diagnosis of pituitary macroadenoma with mass effect
was made.
The symptoms gradually regressed with good clinical
improvement. After sixteen day of admission, the patient
went into premature labor at 34 weeks and five days. After
a review by the obstetricians, she was booked for
emergency caesarean section and the anesthetists were
informed.
Because the CT scan showed evidence of raised intracranial
pressure, general anesthesia with the relaxant technique
was used with sodium thiopentone, non-depolarizing
muscle relaxant, opioid analgesics and oxygen/air. Sodium
thiopentone was used for maintenance of anesthesia in
intermittent bolus doses as that would prevent further rise
in intracranial pressure and the possible risk of bleeding if
the available volatile agent, halothane was used. Anes-
thesia by the corresponding author was uneventful and
the patient recovered satisfactorily. She was taken to the
intensive care unit for postoperative care and close
monitoring.
She recovered full consciousness in ICU. On the second
postoperative day, she was resumed on oral bromocriptine
with the following postoperative drugs; ampiclox, metro-
nidazole, pethidine and promethazine. The following day,
she had complained of restlessness before she was
discharged to the ward on the third postoperative day by
2 pm in fairly satisfactory condition. Later that day at
about 11:30 pm, the duty doctors were called to see the
patient on account of sudden and sustained rise in
blood pressure. On examination she was unconscious
and afebrile. The blood pressure was 210/110 mmHg and
the pulse rate was 150 beats per minute.
A diagnosis of accelerated hypertension with encephalo-
pathy was made and the following drugs prescribed;
intravenous bolus dose of hydralazine 5 mg stat, then
40 mg in a litre of 5% dextrose in water to run at ten drops
per minute with quarter hourly monitoring of blood
pressure. About 15 minutes later the patient started
gasping and went into cardiac arrest. Attempts at
resuscitation failed. An autopsy was not done.
Discussion
Prolactin secreting adenomas are the most commonly
encountered pituitary tumours in women of child bearing
age [3]. Because it interferes with the hypothalamic –
pituitary – ovarian axis at various levels, it is believed to
be responsible for about a third of all cases of female
infertility.
The relationship between pregnancy and the growth of
prolactinomas was first identified in the 1970s when it was
observed that in women who had recovered fertility
following treatment with ovulation inducing drugs or
bromocriptine, pregnancy was associated with pituitary
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defects that required surgery while others had their vision
restored to normal spontaneously after delivery [1].
Molitch has summarized the recent findings on the effects
of pregnancies on prolactinomas [5]. While the risk of
clinically significant enlargement for women with micro-
prolactinomas is 1.3%, the risk of enlargement for women
with untreated macroprolactinomas is 23.2%. There is a
less likely chance of symptomatic growth during preg-
nancy after shrinkage with bromocriptine even after it is
discontinue [5].
It has been suggested that re-introduction of bromo-
criptine is the preferred treatment for the pregnant woman
with prolactinoma who becomes symptomatic. It has been
reported that most cases quickly show regression of
symptoms such as headache and signs (visual field
changes) of tumour enlargement.
The history in this case appears inadequate as there is no
indication of a possible use of bromocriptine before
pregnancy as there was a positive history of menstrual
irregularities.
There was clinical improvement in our patient after
introduction of bromocriptine up to the time she went
into labor at nearly 35 weeks. An emergency caesarian
section was carried out under general anesthesia with the
delivery of a live baby with an Apgar score of 8 after
5 minutes.
She was transferred to the intensive care unit for close
monitoring and observation. She had a bout of pyrexia on
the second postoperative day with a return to normal
temperature after administration of an antipyretic. The
patient had been screened for malarial parasites and
treated for malaria before caesarean delivery. Other events
were uneventful except for a complaint of restlessness,
before she was discharged to the ward. Within the next ten
hours, she had developed accelerated hypertension and
died. Bromocriptine shares with other ergot alkaloids the
property of vasoconstriction, with the potential for serious
tissue injury [6]. Hypertension [7] and cardiac injury has
been associated with bromocriptine use in the postpartum
period [8].
Because of these rare but serious side effects which may also
include cerebral angiopathy, strokes and seizures, its use is
notadvocatedinthepostpartumperiod[9].Perhapsalower
starting dose of bromocriptine should have been used.
It was for this reason that oxytocin was used for uterine
contraction following caesarean delivery in order to avoid
the use of egometrine, another ergot alkaloid.
Though an autopsy was not carried out in this patient, a
catastrophic complication of a pituitary tumour (espe-
cially a macroadenoma) related to sudden intratumoural
infarction or haemorrhage (pituitary apoplexy) [10] might
be a possibility.
Conclusion
Prolactinomas are reportedly rare during pregnancy and are
known to respond to treatment with bromocriptine. If the
pregnancy is far from term and the clinical features are
unresponsive to bromocriptine, surgery is advised. If near
term, the woman is delivered before neurosurgery. Anes-
thesia for caesarean delivery and ICU care were fairly
uneventful. The use of dopamine agonists like bro-
mocriptine in the postpartum period should be reviewed.
This rare case also highlights the pitfalls that clinicians
may encounter in the management of such patients
especially when related literature from the region is scarce.
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